Infection image: reoccurrence of Kaposi`s sarcoma after SARS-CoV-2 mRNA vaccination in an HIV-infected patient

Infection. 2024 Feb;52(1):283-284. doi: 10.1007/s15010-023-02121-9. Epub 2023 Dec 6.

Authors

Florian Hitzenbichler¹, Markus Weber², Bernd Salzberger^{3

3}

Affiliations

¹ Department of Infection Prevention and Infectious Diseases, University Hospital Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Germany.
² Department of Sarcoma Surgery, Barmherzige Brueder Regensburg, Prüfeninger Str. 86, 93049, Regensburg, Germany.
³ Department of Infection Prevention and Infectious Diseases, University Hospital Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Germany. bernd.salzberger@ukr.de.

No abstract available

MeSH terms

Antibodies, Viral
COVID-19* / prevention & control
HIV Infections* / complications
Humans
RNA, Messenger
SARS-CoV-2 / genetics
Sarcoma, Kaposi* / diagnosis
Vaccination

Substances

RNA, Messenger
Antibodies, Viral